…oncolytic virus to treat glioblastoma. Mustang Bio, a clinical-stage biopharmaceutical company, is developing the combination therapy and sponsoring the phase 1 study. The combination study is supported by two separate…
…up for our monthly newsletter. Page sources BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO. Yahoo. Retrieved from: https://www.yahoo.com/now/biontech-presents-encouraging-phase-1-143000094.html. Accessed: 09/12/2022….
…from: https://news.yale.edu/2022/03/10/yale-scientists-supercharge-cancer-fighting-t-cells. Accessed: 03/11/2022. A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metabolism. Retrieved from: https://www.cell.com/cell-metabolism/pdf/S1550-4131(22)00053-5.pdf. Accessed: 03/11/2022….
…for our monthly email newsletter and other communications. Page sources Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial. Biospace. Retrieved from: https://www.biospace.com/article/releases/anixa-biosciences-announces-treatment-of-first-patient-in-its-ovarian-cancer-car-t-clinical-trial/. Accessed: 09/09/2022….
…sources Study supports virotherapy as a potential treatment for brain tumors. University of Alabama Birmingham. Retrieved from: https://www.uab.edu/news/research/item/12589-study-supports-virotherapy-as-a-potential-treatment-for-brain-tumors. Accessed: 02/08/2022. Long-term survival with glioblastoma multiforme. Oxford Academic. Retrieved from: https://academic.oup.com/brain/article/130/10/2596/376628….
…cancer and ovarian cancer. Lung cancer and ovarian cancer are two common types of solid tumors. Lung cancer is the second most common type of cancer (behind breast cancer). Ovarian…
…patients. Page sources With Approval for Axi-cel in Second-line on the Horizon, CAR T-Cell Therapy Poised to Enter New Phase. American Journal of Managed Care. Retrieved from: https://www.ajmc.com/view/with-approval-for-axi-cel-in-second-line-on-the-horizon-car-t-cell-therapy-poised-to-enter-new-phase. Accessed: 02/16/2022….
…GET UPDATES ABOUT ACGT RESEARCHERS Page sources Quantitative imaging of apoptosis following oncolytic virotherapy by magnetic resonance fingerprinting aided by deep learning. Nature Biomedical Engineering. Retrieved from: https://www.nature.com/articles/s41551-021-00809-7. Accessed: 01/14/2022….
…today to further advance our research to find cures for cancer. Page sources A Cancer Treatment Makes Leukemia Vanish, But Creates More Mysteries. New York Times. Retrieved from: https://www.nytimes.com/2022/02/02/health/leukemia-car-t-immunotherapy.html. Accessed:…
…testing and research. Through clinical trials, they may lead to breakthroughs ultimately curing cancer. Alliance for Cancer Gene Therapy believes a breakthrough is coming. The question is “when” a cure comes, not “if” one emerges. The sooner the…
https://www.youtube.com/watch?v=mMGsaw0W0lE…
https://www.youtube.com/watch?v=9-KNerTWgRs&authuser=0 With guidance from our Scientific Advisory Council and Board of Directors, the organization considers funding projects with robust scientific foundations and clearly defined paths to the clinic and the…
https://www.youtube.com/watch?v=lIumUed7ZPI With success in overcoming blood cancers established, our current funding priorities focus on new curative strategies for the most difficult-to-treat solid tumor cancers – glioblastoma, a brain cancer, and…
…T-cell therapy he hopes will achieve dramatic results. “There’s an old saying that I like,” says Powell. “All patients deserve an optimistic doctor.” https://www.youtube.com/watch?v=1xRSTH9IbsM Unlike traditional chemotherapy and radiation, Dr….
…Cancer Research Institute. Retrieved from: https://www.cancerresearch.org/en-us/immunotherapy/treatment-types/immunomodulators-checkpoint-inhibitors. Accessed: 03/18/2022. Side Effects of Immunotherapy. American Society of Clinical Oncology. Retrieved from: https://www.cancer.net/navigating-cancer-care/how-cancer-treated/immunotherapy-and-vaccines/side-effects-immunotherapy. Accessed: 03/22/2022. PTP1B Is an Intracellular Checkpoint that Limits T-cell…
…on the ACGT website. Page sources Key Statistics for Pancreatic Cancer. American Cancer Society. Retrieved from: https://www.cancer.org/cancer/types/pancreatic-cancer/about/key-statistics.html. Accessed: 09/29/2023. Pancreatic Cancer Prognosis. Johns Hopkins Medicine. Retrieved from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/pancreatic-cancer/pancreatic-cancer-prognosis. Accessed: 09/29/2023….
…6 things to know. National Cancer Institute. Retrieved from: https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-amtagvi-til-therapy-melanoma. Accessed: 03/15/2024. Breakthrough Treatment for Solid Tumors With TIL Therapy. University of Maryland Medical Center. Retrieved from: https://www.umms.org/ummc/pros/physician-briefs/cancer/immunotherapy/til-therapy. Accessed: 03/15/2024….
…one of HLA antigens A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P, and have a tumor expressing the MAGE-A4 antigen. Tecelra, manufactured by Adaptimmune, is administered intravenously as a single dose. Subscribe to…
…is for patients with advanced (stage 3) or metastatic (stage 4) triple negative (ER-, PR- or HER2-positive) breast cancer that expresses the protein mesothelin. Clinical trial for people with metastatic…
When Noriyuki Kasahara, MD, PhD, was a student in medical school, he watched his aunt lay in a coma for nearly a year, dying of glioblastoma. It was then that…
